Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: Pallarés-Carratalá, Vicente; barrios, vivencio; Fierro González, David; Polo Garcia, Jose; Cinza-Sanjurjo, Sergio
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion StudyAutoria
Data de publicació
2023Editor
MDPICita bibliogràfica
Pallarés-Carratalá, V.; Barrios, V.; Fierro-González, D.; Polo-García, J.; Cinza-Sanjurjo, S. Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESAOpinion Study. Int. J. Environ. Res. Public Health 2023, 20, 2388. https:// doi.org/10.3390/ijerph20032388Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
https://www.mdpi.com/1660-4601/20/3/2388Versió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
Objective: The aim of this study was to evaluate, through a survey, the opinion of primary
care (PC) physicians on the magnitude of dyslipidemia and its degree of control in their clinical
practice. Materials and ... [+]
Objective: The aim of this study was to evaluate, through a survey, the opinion of primary
care (PC) physicians on the magnitude of dyslipidemia and its degree of control in their clinical
practice. Materials and methods: An ecological study was carried out, in which the physicians were
invited to participate by means of an online letter. Data were collected at a single timepoint and
were based only on the experience, knowledge, and routine clinical practice of the participating
physician. Results: A total of 300 physicians answered the questionnaire and estimated the prevalence
of dyslipidemia between 2% and 80%. They estimated that 23.5% of their patients were high-risk,
18.2% were very high-risk, and 14.4% had recurrent events in the last 2 years. The PC physicians
considered that 61.5% of their patients achieved the targets set. The participants fixed the presence of
side-effects to statins at 14%. The statin that was considered safest with regard to side-effects was
rosuvastatin (69%). Conclusions: PC physicians in Spain perceive that the CVR of their patients is
high. This, together with the overestimation of the degree of control of LDL-C, could justify the
inertia in the treatment of lipids. Moreover, they perceive that one-sixth of the patients treated with
statins have side-effects. [-]
Publicat a
Int. J. Environ. Res. Public Health 2023, 20(3).Entitat finançadora
Fundacion SEMERGEN
Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- MED_Articles [667]
Except where otherwise noted, this item's license is described as © 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).